Please login to the form below

Not currently logged in

Alnylam takes off on APOLLO trial results

AlnylamProvides first late-stage evidence on the biotech's gene-silencing platform

UCB’s antiepileptic drug gains new US indication

UCBFDA approves Briviact as a monotherapy to treat POS

With US approval, GSK now needs rapid uptake for COPD triple

GSK GlaxoSmithKline houseAims to quickly launch the predicted blockbuster to revive its R&D portfolio

NICE says OK to Opdivo for lung cancer via CDF

Bristol-Myers Squibb (BMS) buildingComes after BMS drops the price of its PD-1 inhibitor

MSD's Keytruda wins new bladder cancer indication in Europe

merck-keytruda-pembrolizumab-melanomaWill treat locally advanced or mUC patients

AbbVie and Roche plan Venclexta combo filings in leukaemia

MURANO trial shows the duo’s treatment extends PFS

Teva offloads women's health unit in quickfire deals

TevaThe Israeli pharma group is also set to sell its oncology and pain business

CHMP backs maintenance therapy for Tesaro's Zejula

Swiss biotech's PARP inhibitor recommended for approval in ovarian cancer

PuzzleForming a picture of health

As life expectancy increases how can stakeholders ensure the last decades of life are healthy ones?

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

OUTiCO Case Study - Product Launch
An insight into Multi-Channel Account Management
At OUTiCO we often talk about moving away from traditional methods, embracing change, and offering an exceptional outsourcing service, but what does that mean day to day?...
Why AI might be the rep’s best friend
When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...